Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada Canada Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada Canada Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
a man and woman holding cups ;

Parkinson's disease

See how Neria™ products are used for treatment of Parkinson’s disease
Request sample Contact us

What is Parkinson’s disease?

Parkinson’s disease is a degenerative disorder of the central nervous system that may result in the deterioration of the patient’s motor skills, speech, and other functions.
a man and woman sitting on a bench ;

Symptoms

People living with Parkinson's disease are likely to experience notable symptoms. All symptoms are best identified and addressed in collaboration with a healthcare professional. As a general reference, some main symptoms are:1

  • Muscle tremors  
  • Slower and/or rigid body movement
  • Unsteady posture  
  • Small handwriting  

Causes

Parkinson's disease may be described as a loss of nerve cells in the brain. Without these nerve cells, dopamine levels in the brain drop. As dopamine is essential to the body's ability to regulate movement, the loss of it can lead to the symptoms listed above.

Since research is still ongoing to understand more about Parkinson's disease, there is still a lot to learn. What is known is that Parkinson's disease can be passed down through genetics, but no external causes/triggers have been confirmed.

Treatment of Parkinson’s disease with apomorphine

Apomorphine is used to treat Parkinson's disease. It may be prescribed to patients who aren't responding well to other treatments or who experience frequent "off" periods and less control.

Apomorphine is administered subcutaneously: 

  • By intermittent injections with a ready-loaded disposable pen
  • As a continuous infusion using a syringe driver infusion pump with a pre-filled syringe 

Continous Infusion therapy 

Continuous infusion therapy with apomorphine can help improve the quality of life for some patients. The patient uses a battery-driven, syringe-driver infusion pump to deliver a specified continuous amount of the drug when required, adjusting the amount as needed during the day.2 To deliver apomorphine, the patient inserts an infusion set under the skin and connects it to the infusion pump. 

Our Neria™ infusion sets 

Neria™Guard, Neria™Soft & Neria™ infusion sets are intended for the subcutaneous infusion of apomorphine for Parkinson’s disease.

Neria™Guard is also intended for the subcutaneous infusion of foslevodopa/foscarbidopa for Parkinson’s disease.

The choice of medication and method of administration rely on the assessment of healthcare professionals.

Infusion Sets

diagram

Neria™

The Neria™ infusion set is a steel needle infusion set designed for ease of use. The Neria™ infusion set is inserted at a 90-degree angle.

View details

Infusion Sets

diagram

Neria™Guard

A soft cannula infusion set with an integrated insertion device for simple insertions by the touch of a button. A retractable needle may help prevent accidental needle sticks and increase comfort during insertion.

View details

Infusion Sets

a light bulb with a white background

Neria™Soft

A soft cannula infusion set for variable angled insertion and can be disconnected at site.

View details

Help with using our products

The Neria™ infusion set range is built with ease of use in mind, but it's crucial to follow the advice of healthcare professionals and consult the Instruction For Use (IFU) when using an infusion set.
Below you can find some basic info about using a Neria™Guard infusion set.
How to use Neria™Guard infusion set ;

How to use the Neria™Guard infusion sets

Watch our instruction videos and quickly learn how to use the Neria™Guard infusion set.

Please refer to the Instructions For Use (IFU) for a complete list of all information.

The Neria™ product range 

Neria™Guard, Neria™Soft & Neria™infusion sets are tested and used for subcutaneous infusion treatment for Parkinson’s disease.

The Neria™ product range offers a wide variety of infusion sets with different features to help provide more options for patients with Parkinson's disease. 

For an overview of our Neria™ infusion set range for Parkinson's disease, including specifications, please see the table below*.

 

Product Specifications

Neria™Guard

Neria™

Neria™Soft

   

Cannula

Soft

Stainless Steel

Soft

   

Insertion angle

90 degrees

90 degrees

20-45 degrees

   

Disconnection feature

Yes at site

No

Yes at site

   

Needle / Introducer needle gauge

G27

G27 or G29

G27

   

Needle lengths

6 or 9 mm

6, 8, 10
or 12 mm

13 or 17mm

   

Tubing lengths

12, 60, 110 cm

60, 110 cm

60, 110 cm

   

Adhesive

Built-in

Built-in

Built-in

   

Hidden needle

Yes

-

-

   

Intended to use for Parkinson’s disease

Yes

Yes

Yes

   

 

*For information about type of medication that has been tested for use with the infusion set, please refer to the Instructions For Use.

Our Infusion Therapy Areas

Therapy area

a man holding his hands together

Pain management

Learn about Neria™ infusion sets in the area of pain management and palliative care.

Read more

Therapy area

a person holding a child

Thalassemia

Treatments of Thalassemia using Neria™ infusion sets.

Read more

Therapy area

a man holding a woman

Primary immunodeficiency

Learn how Neria™ infusion sets are used in primary immunodeficiency treatments.

Read more

1. Cleveland Clinic: my.clevelandclininc.org. Reviewed April 15, 2022. Accessed February 1, 2024. https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview

2. Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25. PMID: 30055903.

 

Disclaimer: This materials can only be used in markets where the concerned mentioned products have been approved for the drugs mentioned in this promotional material (drugs that are listed in IFU used in the local market).This page is for your reference only, to see website for local specific information, please visit your country's website.

The Convatec name, Hug icon and strapline are trademarks of Convatec.

AP-70348-GBR-ENG-v1  (v1.0)

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?